{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:18:19Z","timestamp":1793546299113,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974080"],"award-info":[{"award-number":["81974080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170640"],"award-info":[{"award-number":["82170640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Project of Chinese Chronic Hepatitis B Clinical Cure Project","award":["ZFGC202211207"],"award-info":[{"award-number":["ZFGC202211207"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30954"],"award-info":[{"award-number":["2022JJ30954"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-85012-9","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T04:01:30Z","timestamp":1735876890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models"],"prefix":"10.1038","volume":"15","author":[{"given":"Chuan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"85012_CR1","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. (World Health Organization, 2024)."},{"key":"85012_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","volume":"4","author":"PA Revill","year":"2019","unstructured":"Revill, P. A. et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol. Hepatol. 4, 545\u2013558 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"85012_CR3","first-page":"3","volume":"41","author":"H You","year":"2023","unstructured":"You, H., Wang, F. & Li, T. Guidelines for the prevention and treatment of chronic hepatitis B (2022 version). Chin. J. Infect. Dis. 41, 3\u201328 (2023).","journal-title":"Chin. J. Infect. Dis."},{"key":"85012_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin, S. K. et al. Asian-pacific clinical practice guidelines on the management of hepatitis B: A 2015 update. Hepatol. Int. 10, 1\u201398 (2016).","journal-title":"Hepatol. Int."},{"key":"85012_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"MF Yuen","year":"2018","unstructured":"Yuen, M. F. et al. Hepatitis B virus infection. Nat. Rev. Dis. Primers. 4, 1\u201320 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"85012_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone, M. & Guidotti, L. G. Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22, 19\u201332 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"85012_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman, S. L. Liver fibrosis \u2013 from bench to bedside. J. Hepatol. 38, 38\u201353 (2003).","journal-title":"J. Hepatol."},{"key":"85012_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","volume":"56","author":"EL Ellis","year":"2012","unstructured":"Ellis, E. L. & Mann, D. A. Clinical evidence for the regression of liver fibrosis. J. Hepatol. 56, 1171\u20131180 (2012).","journal-title":"J. Hepatol."},{"key":"85012_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3350\/cmh.2017.0078","volume":"23","author":"RC Lo","year":"2017","unstructured":"Lo, R. C. & Kim, H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin. Mol. Hepatol. 23, 302\u2013307 (2017).","journal-title":"Clin. Mol. Hepatol."},{"key":"85012_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","volume":"31","author":"ME Zoubek","year":"2017","unstructured":"Zoubek, M. E., Trautwein, C. & Strnad, P. Reversal of liver fibrosis: From fiction to reality. Best Pract. Res. Clin. Gastroenterol. 31, 129\u2013141 (2017).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"85012_CR11","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560\u20131599 (2018).","journal-title":"Hepatology"},{"key":"85012_CR12","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370\u2013398 (2017).","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"85012_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","volume":"8","author":"LB Seeff","year":"2010","unstructured":"Seeff, L. B. et al. Complication rate of Percutaneous Liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin. Gastroenterol. Hepatol. 8, 877\u2013883 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"85012_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","volume":"2","author":"F Piccinino","year":"1986","unstructured":"Piccinino, F., Sagnelli, E., Pasquale, G. & Giusti, G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J. Hepatol. 2, 165\u2013173 (1986).","journal-title":"J. Hepatol."},{"key":"85012_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey, D. C. et al. Liver Biopsy.\u00a0Hepatology  49, 1017\u20131044 (2009).","journal-title":"Hepatology"},{"key":"85012_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/jcp.53.7.541","volume":"53","author":"F Borg","year":"2000","unstructured":"Borg, F. et al. A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals. J. Clin. Pathol. 53, 541\u2013548 (2000).","journal-title":"J. Clin. Pathol."},{"key":"85012_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","volume":"69","author":"R Loomba","year":"2020","unstructured":"Loomba, R. & Adams, L. A. Advances in non-invasive assessment of hepatic fibrosis. Gut 69, 1343\u20131352 (2020).","journal-title":"Gut"},{"key":"85012_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526 (2003).","journal-title":"Hepatology"},{"key":"85012_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"85012_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","volume":"65","author":"M Lemoine","year":"2016","unstructured":"Lemoine, M. et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut 65, 1369\u20131376 (2016).","journal-title":"Gut"},{"key":"85012_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer, P. J. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol. 13, 372\u2013374 (1991).","journal-title":"J. Hepatol."},{"key":"85012_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3851\/IMP1621","volume":"13","author":"YF Liaw","year":"2010","unstructured":"Liaw, Y. F., Brunetto, M. R. & Hadziyannis, S. The natural history of chronic HBV infection and geographical differences. Antivir Ther. 15, 25\u201333\u00a0(2010).","journal-title":"Antivir Ther."},{"key":"85012_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera, L., Friedrich-Rust, M. & Loomba, R. Noninvasive Assessment of Liver Disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156, 1264\u20131281e4 (2019).","journal-title":"Gastroenterology"},{"key":"85012_CR24","first-page":"100067","volume":"2","author":"K Patel","year":"2020","unstructured":"Patel, K. & Sebastiani, G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEPReport 2, 100067 (2020).","journal-title":"JHEPReport"},{"key":"85012_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1148\/radiol.2016160863","volume":"284","author":"M Wagner","year":"2017","unstructured":"Wagner, M. et al. Technical failure of MR Elastography examinations of the liver: Experience from a large single-center study. Radiology 284, 401\u2013412 (2017).","journal-title":"Radiology"},{"key":"85012_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00535-013-0819-9","volume":"49","author":"J Boursier","year":"2014","unstructured":"Boursier, J. et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. J. Gastroenterol. 49, 527\u2013537 (2014).","journal-title":"J. Gastroenterol."},{"key":"85012_CR27","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1038\/s41598-024-63095-8","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients. Sci. Rep. 14, 12081 (2024).","journal-title":"Sci. Rep."},{"key":"85012_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-5926-3-8","volume":"3","author":"T Poynard","year":"2004","unstructured":"Poynard, T. et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp. Hepatol. 3, 8 (2004).","journal-title":"Comp. Hepatol."},{"key":"85012_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/14737159.4.5.593","volume":"4","author":"FF Poordad","year":"2004","unstructured":"Poordad, F. F. FIBROSpect II: A potential noninvasive test to assess hepatic fibrosis. Expert Rev. Mol. Diagn. 4, 593\u2013597 (2004).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"85012_CR30","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cgh.2013.02.026","volume":"11","author":"PG Northup","year":"2013","unstructured":"Northup, P. G. & Caldwell, S. H. Coagulation in Liver Disease: A guide for the Clinician. Clin. Gastroenterol. Hepatol. 11, 1064\u20131074 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"85012_CR31","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1053\/j.gastro.2008.08.060","volume":"135","author":"T Andreani","year":"2008","unstructured":"Andreani, T., Serfaty, L., Poupon, R. & Chazouilleres, O. Need to strictly define Hepatitis B Virus Immunotolerant patients to avoid unnecessary liver biopsy. Gastroenterology 135, 2155\u20132156 (2008).","journal-title":"Gastroenterology"},{"key":"85012_CR32","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1016\/j.cgh.2020.03.001","volume":"18","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Persistent low level of Hepatitis B Virus promotes fibrosis progression during therapy. Clin. Gastroenterol. Hepatol. 18, 2582\u20132591e6 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"85012_CR33","doi-asserted-by":"crossref","unstructured":"Herlong, H. F. & Mitchell, M. C. Jr Laboratory Tests. in Schiff\u2019s Diseases of the Liver 17\u201343 (John Wiley & Sons, Ltd, 2011).","DOI":"10.1002\/9781119950509.ch2"},{"key":"85012_CR34","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/jgh.15871","volume":"37","author":"Y Ha","year":"2022","unstructured":"Ha, Y., Chon, Y. E., Kim, M. N., Lee, J. H. & Hwang, S. G. Gamma-Glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 37, 1624\u20131632 (2022).","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-85012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-85012-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-85012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:13:16Z","timestamp":1736259196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-85012-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85012"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-85012-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study obtained the ethical approval from the Institutional Ethics Committee of Xiangya Hospital of Central South University, with informed consent waived (NO.202205120). The trial was registered with  (NCT05560503).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"571"}}